DuPont is ripping higher after an impressive beat — here’s our next move

DuPont is ripping higher after an impressive beat — here’s our next move

DuPont delivered an impressive earnings beat on Tuesday by navigating disruptions from the war in Iran, sending shares of the maker of medical packaging, clean-water technology, and industrial products soaring. Challenges remain, but we’re not selling into strength. Revenue in the three months ended in March rose 4% to $1.68 billion, topping the LSEG consensus…

Read More
What it means for workers

What it means for workers

With companies spending more than ever on artificial intelligence, they are also tracking how employees use AI in unprecedented detail. Yet many CEOs hope, but still can’t tell, if it’s making workers more productive.  More than two-thirds of enterprises still rely on estimates, like time saved or projected cost reductions, rather than measured financial results…

Read More
FDA Commissioner Marty Makary defends Replimune drug approval decision

FDA Commissioner Marty Makary defends Replimune drug approval decision

Martin Makary, commissioner of the Food and Drug Administration (FDA), during a news conference at the US Food and Drug Administration headquarters in Silver Spring, Maryland, US, on Tuesday, April 28, 2026. Valerie Plesch | Bloomberg | Getty Images U.S. Food and Drug Administration Commissioner Marty Makary defended himself in a CNBC interview aired Tuesday…

Read More